The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD 7.47 billion in ...

‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because ...

In this installment of Rebelliously Curious, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing technology. Joining us is Neal Baer, M.D.—pediatrician, ...

A molecular diagnostics start-up founded by former IISc professor and biotech entrepreneur Vijay Chandru has recently opened a laboratory in Bengaluru for developing diagnostics for rare diseases like ...

The research teams at LV Prasad Eye Institute under the Centre for Ocular Regeneration (CORE) at the Brien Holden Research Centre, organized the second edition of the ‘Future is Here’.

Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic ...

Examining humanity's need for control, the anxiety of uncertainty, and how embracing life's mysteries can transform fear into ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction ...

The National Agriculture and Food Research Organization (NARO) has developed GenEditScan, a simple k-mer analysis tool and is ...

Ross Bjella, Kelyniam's CEO, announced today a number of important updates ahead of the recurring announcements associated with the Company's traditional March corporate disclosures:  Kelyniam Global ...

The woolly mammoth has been extinct for thousands of years, but Colossal Biosciences is pursuing technology that could help ...